SALIX PHARMACEUTICALS LTD Accounts Receivable, Allowance for Credit Loss, Current
SALIX PHARMACEUTICALS LTD had Accounts Receivable, Allowance for Credit Loss, Current of $2.60 million as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2015-03-02
- 2014-12-31: Accounts Receivable, Allowance for Credit Loss, Current $2.60M.
- 2013-12-31: Accounts Receivable, Allowance for Credit Loss, Current $2.80M.
- 2012-12-31: Accounts Receivable, Allowance for Credit Loss, Current $2.50M.
- 2011-12-31: Accounts Receivable, Allowance for Credit Loss, Current $2.00M; Accounts Receivable, Allowance for Credit Loss, Current as first filed $800.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2014-12-31 | $2.60M 10-K · filed 2015-03-02 | |
| 2013-12-31 | $2.80M 10-K · filed 2015-03-02 | |
| 2012-12-31 | $2.50M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $2.00M 10-K · filed 2013-03-01 | $800.00K 10-K · filed 2012-02-28 |
| 2010-12-31 | $500.00K 10-K · filed 2012-02-28 |